Min Mao
Ueruemqi, 830001, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Expert consensus on a multidisciplinary approach for the management of multiple myeloma-related bone disease.
Journal: Cancer pathogenesis and therapy
Published: September 02, 2024
Case report: A case of effective treatment of primary myelofibrosis with nodular panniculitis using ruxolitinib combined with corticosteroids.
Journal: Frontiers in oncology
Published: April 04, 2024
Hypermethylation of the FOXP3 gene regulates Tregs immunodysregulation in chronic idiopathic thrombocytopenic purpura.
Journal: Allergologia et immunopathologia
Published: February 23, 2024
Disseminated visceral Kaposi's sarcoma after allogeneic hematopoietic stem cell transplantation: a case report.
Journal: The Journal of international medical research
Published: May 12, 2023
Oligosecretory Waldenström macroglobulinemia exhibits excellent treatment response and outcomes.
Journal: Haematologica
Published: April 27, 2023
Mutational Spectrum and Prognosis Analysis of Young Patients with Diffuse Large B-Cell Lymphoma Based on Next-Generation Sequencing
Journal: Zhongguo shi yan xue ye xue za zhi
Published: April 25, 2023
8p11 myeloproliferative syndrome with TRIM24/FGFR1 and FGFR1/TRIM24 fusion gene positive: a case report
Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
Published: January 28, 2023
Identification of FAT4 as a positive prognostic biomarker in DLBCL by comprehensive genomic analysis.
Journal: Clinical and experimental medicine
Published: October 21, 2022
A Multi-Center, Real-World Study of Chidamide for Patients With Relapsed or Refractory Peripheral T-Cell Lymphomas in China.
Journal: Frontiers in oncology
Published: July 30, 2021
Treatment and outcome patterns of patients with Waldenström's macroglobulinemia: a large, multicenter retrospective review in China.
Journal: Leukemia & lymphoma
Published: June 09, 2021
CARD11 is a novel target of miR-181b that is upregulated in chronic lymphocytic leukemia.
Journal: Biomarkers in medicine
Published: May 27, 2021
Effect of rhG-CSF Combined With Decitabine Prophylaxis on Relapse of Patients With High-Risk MRD-Negative AML After HSCT: An Open-Label, Multicenter, Randomized Controlled Trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: October 27, 2020
Last Updated: 09/26/2026